Migraine Treatment

Botox® Injection Therapy for Chronic Migraine

Woman in pink jacket holds her temples against pink backdrop, symbolic image for Migraine Treatment at BONITAS in Nuremberg

Chronic migraine is more than “just a headache”. It is debilitating, isolating, exhausting. It takes away your days. Quality of life. Freedom. And often it is resistant to pills, injections, or alternative methods.

The good news: Botox® is an officially approved migraine therapy – scientifically proven, gentle in application, with the aim of reducing the number of migraine days. At BONITAS we perform the treatment with precision and personal care – for everyone whose daily life is severely limited by migraine.

At a glance

Chronic migraine can be treated preventively with Botox following the PREEMPT protocol. The aim is to reduce the number of headache days; how much varies from person to person.

Treatment time
20–30 minutes
Method
botulinum toxin following the PREEMPT protocol (31 points)
Indication
chronic migraine (15 or more headache days a month, at least 8 of them with migraine)
Onset of effect
after 2–4 weeks
Duration of effect
3 months, repeat treatment recommended

How does Botox® work for migraines?

Botulinum toxin (Botox®) blocks the release of pain messengers at the nerve endings. This leads to:

The aim: fewer attacks, shorter duration, lower intensity. How clearly the treatment works varies from person to person.

Who is a candidate for migraine treatment with Botox®?

BONITAS checks in a detailed consultation whether you are medically suitable for Botox migraine treatment – and develops a clear treatment plan.

How the treatment at BONITAS works

The injection is performed with very fine needles – almost painless. BONITAS ensures a relaxed, calm atmosphere.

Goals of treatment

First effects usually appear after 2–4 weeks. Whether and how well the treatment works can usually be judged after 2–3 treatments.

Botox® and other treatment options

Botox®

Other options

Why BONITAS?

BONITAS combines medical knowledge with genuine care – so that you can make a well-informed decision about which treatment is right for you.

Frequently asked questions (FAQ)

Costs vary depending on the practice and the number of injections. An up-to-date price list can be found here.

Yes – the effect of botulinum toxin lasts for approximately 12 weeks on average. To control migraines long-term, regular repetition of the treatment is necessary. Whether and how well the treatment works can usually be judged after 2 to 3 treatment cycles. The aim is to reduce headache days and, in the long term, the need for acute medication.

Yes – Botulinum toxin A (OnabotulinumtoxinA) was approved by the EU in 2011 for chronic migraines and often reduces the number of headache days.

Common options include acute medications (triptans, NSAIDs), prophylaxis (beta-blockers, anticonvulsants, CGRP antibodies), and Botox. Alternatives include biofeedback, muscle relaxants, neuromodulation (e.g., occipital nerve stimulation), or in individual cases, invasive procedures.

The “10-20 rule” is about acute medication: you should take pain relievers and migraine medications on no more than 10 days a month and go without them on at least 20 days; otherwise there is a risk of medication-overuse headache. If attacks are frequent or burdensome, preventive treatment may be an option, for example with tablets or CGRP antibodies. Botulinum toxin is approved for this only in chronic migraine (at least 15 headache days a month for more than three months, at least 8 of them with migraine).

Smiling man with dark hair and beard in white coat against light background: Alejandro Marti, specialist in plastic and aesthetic surgery, BONITAS Nuremberg
Get your advice now

If you are considering medical aesthetic treatment, schedule your consultation for an honest assessment tailored to your needs.

Scientific References

4 sources
  1. Dodick DW et al. „OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.“ Headache. 2010. PubMed PMID 20487038
  2. Lanteri-Minet M et al. „Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data.“ Cephalalgia. 2022. PubMed PMID 36081276
  3. Ornello R et al. „Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study.“ Pain and Therapy. 2021. PubMed PMID 33778933
  4. Frank F et al. „CGRP-antibodies, topiramate and botulinum toxin type A in episodic and chronic migraine: A systematic review and meta-analysis.“ Cephalalgia. 2021. PubMed PMID 34130525